These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029 [TBL] [Abstract][Full Text] [Related]
9. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition. Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189 [TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population. Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266 [TBL] [Abstract][Full Text] [Related]
11. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials. Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124 [TBL] [Abstract][Full Text] [Related]
12. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation. Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510 [TBL] [Abstract][Full Text] [Related]
13. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
14. Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment. Cawello W; Bökens H; Nickel B; Andreas JO; Halabi A Epilepsia; 2013 Jan; 54(1):81-8. PubMed ID: 23148731 [TBL] [Abstract][Full Text] [Related]
15. The effect of food on the absorption and pharmacokinetics of rivaroxaban. Stampfuss J; Kubitza D; Becka M; Mueck W Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226 [TBL] [Abstract][Full Text] [Related]
16. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions. Guivarc'h PH; Vachon MG; Fordyce D Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008 [TBL] [Abstract][Full Text] [Related]
18. Concentrations of metronidazole in human plasma and saliva after tablet or gel administration. de C Bergamaschi C; Berto LA; Venâncio PC; Cogo K; Franz-Montan M; Motta RH; Santamaria MP; Groppo FC J Pharm Pharmacol; 2014 Jan; 66(1):40-7. PubMed ID: 24341948 [TBL] [Abstract][Full Text] [Related]